202
Views
10
CrossRef citations to date
0
Altmetric
Hypothesis

Ambroxol for the treatment of fibromyalgia: science or fiction?

&
Pages 1905-1929 | Published online: 16 Aug 2017

References

  • WolfeFSmytheHAYunusMBThe American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria CommitteeArthritis Rheum19903321601722306288
  • ArnoldLMClauwDJMcCarbergBHImproving the recognition and diagnosis of fibromyalgiaMayo Clin Proc201186545746421531887
  • HäuserWZimmerCFeldeEKöllnerVWas sind die Kernsymptome des Fibromyalgiesyndroms? Ergebnisse einer Umfrage der deutschen Fibromyalgie Verband. [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association]Schmerz2008222176183 German18210165
  • WolfeFClauwDJFitzcharlesMAFibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgiaJ Rheumatol20113861113112221285161
  • WolfeFBrahlerEHinzAHäuserWFibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general populationArthritis Care Res2013655777785
  • BrancoJCBannwarthBFaildeIPrevalence of fibromyalgia: a survey in five European countriesSemin Arthritis Rheum201039644845319250656
  • AblinJNOrenACohenSPrevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ)Clin Exp Rheumatol2012306 Suppl 743943
  • LawrenceRCFelsonDTHelmickCGEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: part IIArthritis Rheum2008581263518163497
  • Torgrimson-OjerioBRossRLDieckmannNFPreliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgiaJ Neuroimmunol20142771–216016725457842
  • GarciaJJCidonchaABoteMEHinchadoMDOrtegaEAltered profile of chemokines in fibromyalgia patientsAnn Clin Biochem201451Pt 557658124106344
  • BehmFGGavinIMKarpenkoOUnique immunologic patterns in fibromyalgiaBMC Clin Pathol2012122523245186
  • UçeylerNHäuserWSommerCSystematic review with meta-analysis: cytokines in fibromyalgia syndromeBMC Musculoskelet Disord20111224522034969
  • Rodriguez-PintoIAgmon-LevinNHowardAShoenfeldYFibromyalgia and cytokinesImmunol Lett2014161220020324462815
  • HernandezMEBecerrilEPerezMProinflammatory cytokine levels in fibromyalgia patients are independent of body mass indexBMC Res Notes2010315620525285
  • NugrahaBKorallusCKielsteinHGutenbrunnerCCD3+CD56+ natural killer T cells in fibromyalgia syndrome patients: association with the intensity of depressionClin Exp Rheumatol2013316 Suppl 79S9S15
  • MenziesVLyonDEIntegrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptomsBiol Res Nurs201011438739419933683
  • GürAOktayogluPStatus of immune mediators in fibromyalgiaCurr Pain Headache Rep200812317518118796266
  • UceylerNValenzaRStockMSchedelRSprotteGSommerCReduced levels of antiinflammatory cytokines in patients with chronic widespread painArthritis Rheum20065482656266416871547
  • MenziesVLyonDEElswickRKJrMontpetitAJMcCainNLPsychoneuroimmunological relationships in women with fibromyalgiaBiol Res Nurs201315221922522174319
  • BradleyLAPathophysiology of fibromyalgiaAm J Med200912212 SupplS22S30
  • TakLMCleareAJOrmelJMeta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disordersBiol Psychol201187218319421315796
  • TokerAKucuksenSKucukACiceklerHSerum ischemia-modified albumin and malondialdehyde levels and superoxide dismutase activity in patients with fibromyalgiaClin Lab201460101609161525651705
  • AkbasAInanirABenliIOnderYAydoganLEvaluation of some antioxidant enzyme activities (SOD and GPX) and their polymorphisms (MnSOD2 Ala9Val, GPX1 Pro198Leu) in fibromyalgiaEur Rev Med Pharmacol Sci20141881199120324817295
  • BagisSTamerLSahinGFree radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?Rheumatol Int200525318819014689230
  • Martinez-LavinMFibromyalgia: when distress becomes (un)sympathetic painPain Res Treat2012201298156522110948
  • Vargas-AlarconGAlvarez-LeonEFragosoJMA SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgiaBMC Musculoskelet Disord2012132322348792
  • KernKUWeiserTTopical ambroxol for the treatment of neuropathic pain: a first clinical observationSchmerz2015296632640 German26597641
  • KernKUWeiserTTopical ambroxol for the treatment of neuropathic pain: an initial clinical observationSchmerz201529Suppl 3S89S9626589711
  • KernUWeiserTTopical ambroxol for the treatment of neuropathic or severe nociceptive pain: first case reportsPoster presented at: 9th Congress of the European Pain Federation (EFIC)September 2–5, 2015Vienna, Austria
  • Martinez-MartinezLPerezLAcostaGAmbroxol for fibromyalgia: one-group pretest-posttest open label clinical observationArthritis Rheumatol201668Suppl 1044
  • Martinez-MartinezLAPerezLFBecerril-MendozaLTAmbroxol for fibromyalgia: one group pretest-posttest open-label pilot studyClin Rheumatol20173681879188428466418
  • BeehKMBeierJEsperesterAPaulLDAntiinflammatory properties of ambroxolEur J Med Res2008131255756219073395
  • MalerbaMRagnoliBAmbroxol in the 21st century: pharmacological and clinical updateExpert Opin Drug Metab Toxicol2008481119112918680446
  • LefflerAReckzehJNauCBlock of sensory neuronal Na+ channels by the secreolytic ambroxol is associated with an interaction with local anesthetic binding sitesEur J Pharmacol20106301–3192820044988
  • WeiserTNav1.8 channel blockade as an approach to the treatment of neuropathic painDrugs Future2006317597601
  • WeiserTComparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1.2 channelsNeurosci Lett2006395317918416293367
  • AkopianANSivilottiLWoodJNA tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neuronsNature199637965622572628538791
  • ZimmermannKLefflerABabesASensory neuron sodium channel Nav1.8 is essential for pain at low temperaturesNature2007447714685585817568746
  • BlairNTBeanBPRoles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neuronsJ Neurosci20022223102771029012451128
  • RenganathanMCumminsTRWaxmanSGContribution of Nav1.8 sodium channels to action potential electrogenesis in DRG neuronsJ Neurophysiol200186262964011495938
  • ChenWNLeeCHLinSHRoles of ASIC3, TRPV1, and NaV1.8 in the transition from acute to chronic pain in a mouse model of fibromyalgiaMol Pain2014104024957987
  • CagnieBCoppietersIDeneckerSSixJDanneelsLMeeusMCentral sensitization in fibromyalgia? A systematic review on structural and functional brain MRISemin Arthritis Rheum2014441687524508406
  • SalemiSRethageJWollinaUDetection of interleukin 1β (IL-1β), IL-6, and tumor necrosis factor-α in skin of patients with fibromyalgiaJ Rheumatol200330114615012508404
  • JangYYSongJHShinYKHanESLeeCSDepressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharidePharmacol Toxicol200392417317912753420
  • WangYWangFYPanZEffects of ambroxol combined with low-dose heparin on TNFα and IL-1β in rabbits with acute lung injuryZhongguo Ying Yong Sheng Li Xue Za Zhi2011272231235 Chinese21845882
  • SuXWangLSongYBaiCInhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharideIntensive Care Med200430113314014504727
  • JinXZZhangHThe experiment and clinical study of ambroxol against the airway inflammation of chronic hypoxic rat and patients with COPDEur Respir J200220Suppl. 381658
  • BianchiMMantovaniAErroiADinarelloCAGhezziPAmbroxol inhibits interleukin 1 and tumor necrosis factor production in human mononuclear cellsAgents Actions1990313–4275279
  • PfeiferSZisselGKienastKMüller-QuernheimJReduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxolEur J Med Res1997231291329113503
  • YangBYaoDFOhuchiMAmbroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levelsEur Respir J200219595295812030738
  • ZhangSJJiangJXRenQQAmbroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathwayEur J Pharmacol201677513814826872986
  • XiaDHXiLXvCThe protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor β1 and tumor necrosis factor αMed Oncol201027369770119636975
  • BlancoIBeritzeNArguellesMAbnormal overexpression of mastocytes in skin biopsies of fibromyalgia patientsClin Rheumatol201029121403141220428906
  • GibbsBFSchmutzlerWVollrathIBAmbroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cellsInflamm Res1999482869310202994
  • Zwadlo-KlarwasserGServaisMDSchmutzlerWBrosthardtPBraamUAmbroxol inhibits histamine release from human adenoidal mast cellsInflamm Res199847Suppl 1S16S179561395
  • GibbsBFWolffHHGrabbeJAmbroxol inhibits IgE-dependent mediator secretion from human skin mast cellsInflamm Res200049Suppl 1S17S1810864402
  • Sánchez-DomínguezBBullónPRomán-MaloLOxidative stress, mitochondrial dysfunction and, inflammation common events in skin of patients with fibromyalgiaMitochondrion201521697525662535
  • CorderoMDMoreno-FernandezAMCarmona-LopezMIMitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patientsClin Biochem20104313–141174117620599870
  • StetinováVHeroutVKvetinaJIn vitro and in vivo antioxidant activity of ambroxolClin Exp Med20044315215815599665
  • HongJSKoHHHanESLeeCSInhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxolBiochem Pharmacol20036671297130614505809
  • LedwozywAJablonkaSTusińskaEWplyw ambroksolu na procesy peroksydacyjne w mitochondriach pluc psa. [The effect of ambroxol on peroxidative processes in dog lung mitochondria]Pol Arch Weter1991313–4105113 Polish1842611
  • GillissenABartlingASchoenSSchultze-WerninghausGAntioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitroLung199717542352429195551
  • GasparMBovairaMCarrera-HuesoFJQuerolMJimenezAMorenoLEfectividad de un protocolo de tratamiento topico con dimetilsulfoxido al 50% en el sindrome de dolor regional complejo tipo. [Efficacy of a topical treatment protocol with dimethyl sulfoxide 50% in type 1 complex regional pain syndrome]Farm Hosp2012365385391 Spanish22266201
  • LeeCSJangYYSongJSSongJHHanESAmbroxol inhibits peroxynitrite-induced damage of α1-antiproteinase and free radical production in activated phagocytic cellsPharmacol Toxicol200291314014912427115
  • OttonelloLArduinoNBertolottoMDapinoPManciniMDallegriFIn vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanismBr J Pharmacol2003140473674214534155
  • UçeylerNKewenigSKafkeWKittel-SchneiderSSommerCSkin cytokine expression in patients with fibromyalgia syndrome is not different from controlsBMC Neurol20141418525240423
  • KosmidisMLKoutsogeorgopoulouLAlexopoulosHReduction of intraepidermal nerve fiber density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled studyJ Neurol Sci20143471–214314725304055
  • BelkouchMDansereauMATetreaultPFunctional up-regulation of Nav1.8 sodium channel in Aβ afferent fibers subjected to chronic peripheral inflammationJ Neuroinflamm20141145
  • GaidaWKlinderKArndtKWeiserTAmbroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory painNeuropharmacology20054981220122716182323
  • HamaATPlumAWSagenJAntinociceptive effect of ambroxol in rats with neuropathic spinal cord injury painPharmacol Biochem Behav201097224925520732348
  • MoonJYSongSYoonSYThe differential effect of intrathecal Nav1.8 blockers on the induction and maintenance of capsaicin- and peripheral ischemia-induced mechanical allodynia and thermal hyperalgesiaAnesth Analg2012114121522322127815
  • BettoniLBonomiFGZaniVEffects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patientsClin Rheumatol20133291337134523636794
  • BanfiGLombardiGColombiniAMelegatiGWhole-body cryotherapy in athletesSports Med201040650951720524715
  • McNeillAMagalhaesJShenCAmbroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cellsBrain2014137Pt 51481149524574503
  • AmbrosiGGhezziCZangagliaRLevandisGPacchettiCBlandiniFAmbroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson’s disease cellsNeurobiol Dis20158223524226094596
  • Lawson Health Research InstituteAmbroxol as a treatment for Parkinson’s disease dementia Available from: https://clinicaltrials.gov/ct2/show/NCT02914366. NLM identifier: NCT02914366Accessed July 28, 2017
  • LukasJPockrandtAMSeemannSEnzyme enhancers for the treatment of Fabry and Pompe diseaseMol Ther201523345646425409744
  • SuzukiYChaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher diseaseBrain Dev201335651552323290321
  • NaritaAShiraiKItamuraSAmbroxol chaperone therapy for neuronopathic Gaucher disease: a pilot studyAnn Clin Transl Neurol20163320021527042680
  • La RubiaMRusAMolinaFDel MoralMLIs fibromyalgia-related oxidative stress implicated in the decline of physical and mental health status?Clin Exp Rheumatol2013316 Suppl 79S121S12724373370
  • FatimaGDasSKMahdiAASome oxidative and antioxidative parameters and their relationship with clinical symptoms in women with fibromyalgia syndromeInt J Rheum Dis2015201394526177214
  • CulićOCorderoMDZanić-GrubišićTSerum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia: diagnostic implicationsClin Rheumatol201635102565257127527091
  • CorderoMDDe MiguelMFernandezAMMitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the diseaseArthritis Res Ther2010121R1720109177
  • MeeusMNijsJHermansLGoubertDCaldersPThe role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?Expert Opin Ther Targets20131791081108923834645
  • CorderoMDDiaz-ParradoECarrionAMIs inflammation a mitochondrial dysfunction-dependent event in fibromyalgia?Antioxid Redox Signal201318780080722938055
  • LazzarinALuertiMCapsoniFA study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS)Int J Tissue React1986821571653700005
  • AiharaMDobashiKAkiyamaMNaruseINakazawaTMoriMEffects of N-acetylcysteine and ambroxol on the production of IL-12 and IL-10 in human alveolar macrophagesRespiration200067666267111124650
  • AngDCHilligossJStumpTMast cell stabilizer (ketotifen) in fibromyalgia: phase 1 randomized controlled clinical trialClin J Pain Epub2014113
  • MorreyCBrazinJSeyediNCortiFSilverRBLeviRInteraction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunctionJ Pharmacol Exp Ther20103351768420668055
  • TorresaniCBellafioreSDe PanfilisGChronic urticaria is usually associated with fibromyalgia syndromeActa Derm Venereol200989438939219688152
  • TsilioniIRussellIJStewartJMGleasonRMTheoharidesTCNeuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cellsJ Pharmacol Exp Ther2016356366467226763911
  • ZhengGHongSHayesJMWileyJWChronic stress and peripheral pain: evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathwaysExp Neurol201527330131126408049
  • SturgeonJADarnallBDZwickeyHLProinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal statusJ Pain Res2014770771625506243
  • GeissARohlederNAntonFEvidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgiaPsychoneuroendocrinology201237567168422000300
  • GeLTLiuYNLinXXInhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathwayInt Immunopharmacol201633909826881857
  • RicciardoloFLSorbelloVBenedettoSPaleariDEffect of ambroxol and beclomethasone on lipopolysaccharide-induced nitrosative stress in bronchial epithelial cellsRespiration201589657258225998443
  • FatimaGDasSKMahdiAAOxidative stress and antioxidative parameters and metal ion content in patients with fibromyalgia syndrome: implications in the pathogenesis of the diseaseClin Exp Rheumatol2013316 Suppl 79S128S13324373371
  • ZhaoSPGuoQLWangRKWangEOxidative and anti-oxidative effects of ambroxol on acute hydrochloric acid-induced lung injury in ratsZhong Nan Da Xue Xue Bao Yi Xue Ban2004295586588 Chinese16137054
  • NowakDAntczakAPietrasTBialasiewiczPKrolMProtective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipids in miceEur Respir J199479162916347995392
  • OzgocmenSOzyurtHSogutSAkyolOArdicogluOYildizhanHAntioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concernsRheumatol Int200626759860316283318
  • JiangKWangXMaoXAmbroxol alleviates hepatic ischemia reperfusion injury by antioxidant and antiapoptotic pathwaysTransplant Proc20134562439244523953561
  • ZhangBLiuYProphylaxis against ventilator-induced lung injury by ambroxolZhonghua Yi Xue Za Zhi20008015153 Chinese11798737
  • WuXLiSZhangJMeta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trialsJ Clin Pharmacol201454111199120625174313
  • MaYTTianYPShiHWLvCHLiuJHSunZPEffects of high dose ambroxol on lung injury induced by paraquat in ratsZhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi2007259523526 Chinese17997885
  • YangFSunWYangYSDF1-CXCR4 signaling contributes to persistent pain and hypersensitivity via regulating excitability of primary nociceptive neurons: involvement of ERK-dependent Nav1.8 up-regulationJ Neuroinflamm201512219
  • SchlüterFLefflerAOxidation differentially modulates the recombinant voltage-gated Na+ channel α-subunits Nav1.7 and Nav1.8Brain Res20161648Pt A12713527450927
  • WeiserTPresentation at the German Pain Conference 2005, October 19–22, 2005, Bremen, GermanySchmerz19Suppl 1S512823570068
  • MaesMMihaylovaIKuberaMUytterhoevenMVrydagsNBosmansEIncreased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery diseaseJ Affect Disord20101251–328729420083310
  • MaesMMihaylovaIKuberaMUytterhoevenMVrydagsNBosmansEIncreased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndromeNeuro Endocrinol Lett200930671572220035260
  • WiktorskaJALewinskiAStussMNowakDPietrasTSewerynekEEffects of certain antioxidants on lipid peroxidation process in lung homogenates of L thyroxine-receiving ratsNeuro Endocrinol Lett201031113714620150865
  • PernambucoAPSchetinoLPVianaRSCarvalhoLSd’Avila ReisDThe involvement of melatonin in the clinical status of patients with fibromyalgia syndromeClin Exp Rheumatol2015331 Suppl 88S14S19
  • BlumenthalDEMalemudCJRecent strategies for drug development in fibromyalgia syndromeExpert Rev Neurother201616121407141127362466
  • LawsonKPotential drug therapies for the treatment of fibromyalgiaExpert Opin Investig Drugs201625910711081
  • SanchezACalpenaACClaresBEvaluating the oxidative stress in inflammation: role of melatoninInt J Mol Sci2015168169811700426225957
  • BortolatoBBerkMMaesMMcIntyreRSCarvalhoAFFibromyalgia and bipolar disorder: emerging epidemiological associations and shared pathophysiologyCurr Mol Med201616211913626812920
  • OzgocmenSOzyurtHSogutSAkyolOCurrent concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxideRheumatol Int200626758559716328420
  • KimSKKimSHNahSSAssociation of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean populationJ Rheumatol201340331632223322459
  • SendurOFTuranYTastabanEYeniseyCSerterMSerum antioxidants and nitric oxide levels in fibromyalgia: a controlled studyRheumatol Int200929662963318853166
  • RusAMolinaFGassoMCamachoMVPeinadoMAdel MoralMLNitric oxide, inflammation, lipid profile, and cortisol in normal- and overweight women with fibromyalgiaBiol Res Nurs201618213814626134428
  • CimenOBCimenMYYapiciYCamdevirenHArginase, NOS activities, and clinical features in fibromyalgia patientsPain Med200910581381819523030
  • SeverinaISBussyginaOGPyatakovaNVKhropovYVKrasnoperovRAAmbroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclaseEur J Pharmacol20004071–2616411050291
  • AnfossiGRussoIMassuccoPAdenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiag-gregating effectThromb Res20021051717811864710
  • KimYKJangYYHanESLeeCSDepressant effect of ambroxol on stimulated functional responses and cell death in rat alveolar macrophages exposed to silica in vitroJ Pharmacol Exp Ther2002300262963711805226
  • HuFWangQWangP17β-Estradiol regulates the gene expression of voltage-gated sodium channels: role of estrogen receptor α and estrogen receptor βEndocrine201241227428022169964
  • WangQCaoJHuFEffects of estradiol on voltage-gated sodium channels in mouse dorsal root ganglion neuronsBrain Res201315121823473841
  • SteningKDErikssonOHenrikssonKGHormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized, placebo-controlled trialRheumatology (Oxford)201150354455121078629
  • DehlinMBjersingJErlandssonMCerebrospinal Flt3 ligand correlates to tau protein levels in primary Sjögren’s syndromeScand J Rheumatol201342539439923837643
  • KorszunAYoungEAEnglebergNCFollicular phase hypothalamic- pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndromeJ Rheumatol20002761526153010852283
  • SchafranskiMDMalucelliTMachadoFIntravenous lidocaine for fibromyalgia syndrome: an open trialClin Rheumatol200928785385519263182
  • MarksDMNewhouseADurability of benefit from repeated intravenous lidocaine infusions in fibromyalgia patients: a case series and literature reviewPrim Care Companion CNS Disord20151754088
  • StaudRWeylEEBartleyEPriceDDRobinsonMEAnalgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndromeEur J Pain201418680381224193993
  • StaudRNagelSRobinsonMEPriceDDEnhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled studyPain20091451–29610419540671
  • Arendt-NielsenLFernandez-de-Las-PenasCGraven-NielsenTBasic aspects of musculoskeletal pain: from acute to chronic painJ Man Manip Ther201119418619323115471
  • DeSantanaJMSlukaKACentral mechanisms in the maintenance of chronic widespread noninflammatory muscle painCurr Pain Headache Rep200812533834318765138
  • StaudRPeripheral pain mechanisms in chronic widespread painBest Pract Res Clin Rheumatol201125215516422094192
  • JosephEKLevineJDHyperalgesic priming is restricted to isolectin B4-positive nociceptorsNeuroscience2010169143143520457222
  • AlvarezPChenXBogenOGreenPGLevineJDIB4+ nociceptors mediate persistent muscle pain induced by GDNFJ Neurophysiol201210892545255322914655
  • AlvarezPGearRWGreenPGLevineJDIB4-saporin attenuates acute and eliminates chronic muscle pain in the ratExp Neurol2012233285986522206923
  • SlukaKAPriceMPBreeseNMStuckyCLWemmieJAWelshMJChronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1Pain2003106322923914659506
  • SlukaKAKalraAMooreSAUnilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesiaMuscle Nerve2001241374611150964
  • LawLASlukaKAMcMullenTLeeJArendt-NielsenLGraven-NielsenTAcidic buffer induced muscle pain evokes referred pain and mechanical hyperalgesia in humansPain2008140225426418835099
  • IssbernerUReehPWSteenKHPain due to tissue acidosis: a mechanism for inflammatory and ischemic myalgia?Neurosci Lett199620831911948733302
  • BirdsongWTFierroLWilliamsFGSensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channelsNeuron201068473974921092862
  • FujiiYOzakiNTaguchiTMizumuraKFurukawaKSugiuraYTRP channels and ASICs mediate mechanical hyperalgesia in models of inflammatory muscle pain and delayed onset muscle sorenessPain2008140229230418834667
  • HoheiselUReinöhlJUngerTMenseSAcidic pH and capsaicin activate mechanosensitive group IV muscle receptors in the ratPain20041101–214915715275762
  • YenYTTuPHChenCJLinYWHsiehSTChenCCRole of acid-sensing ion channel 3 in sub-acute-phase inflammationMol Pain20095119126241
  • BennettRMJonesJTurkDCRussellIJMatallanaLAn Internet survey of 2,596 people with fibromyalgiaBMC Musculoskelet Disord200782717349056
  • HäuserWJungEErbslöh-MöllerBThe German fibromyalgia consumer reports: a cross-sectional surveyBMC Musculoskelet Disord2012137422607517
  • ChristidisNGhafouriBLarssonAComparison of the levels of pro-inflammatory cytokines released in the vastus lateralis muscle of patients with fibromyalgia and healthy controls during contractions of the quadriceps muscle: a microdialysis studyPloS One20151012e014385626624891
  • AngDCMooreMNHilligossJTabbeyRMCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot studyPain Med20111281154116121714842
  • AlvarezPGreenPGLevineJDRole for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the ratPain201415561161116724637038
  • ZhiQMYangLTSunHCProtective effect of ambroxol against paraquat-induced pulmonary fibrosis in ratsIntern Med201150181879188721921364
  • BazzichiLGiacomelliCConsensiAOne year in review 2016: fibromyalgiaClin Exp Rheumatol2016342 Suppl 96S145S149
  • LefaucheurJPThe “paradox” of neuropathic pain associated with small-fiber lesions in the context of fibromyalgiaPain201615761364136527183446
  • GauffinJHankamaTKautiainenHHannonenPHaanpääMNeuropathic pain and use of PainDETECT in patients with fibromyalgia: a cohort studyBMC Neurol2013132123409793
  • KoroschetzJRehmSEGockelUFibromyalgia and neuropathic pain – differences and similarities: a comparison of 3057 patients with diabetic painful neuropathy and fibromyalgiaBMC Neurol2011115521612589
  • HäuserWWalittBFitzcharlesMASommerCReview of pharmacological therapies in fibromyalgia syndromeArthritis Res Ther201416120124433463
  • FinnerupNBAttalNHaroutounianSPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisLancet Neurol201514216217325575710
  • UçeylerNSommerCReply: Small fibre neuropathy, fibromyalgia and dorsal root ganglia sodium channelsBrain2013136Pt 9e24723729475
  • DopplerKRittnerHLDeckartMSommerCReduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgiaPain2015156112319232526164586
  • UçeylerNSmall fiber pathology: a culprit for many painful disorders?Pain2016157Suppl 1S60S6626780379
  • RamirezMMartinez-MartinezLAHernandez-QuintelaEVelazco-CasapiaJVargasAMartinez-LavinMSmall fiber neuropathy in women with fibromyalgia: an in vivo assessment using corneal confocal bio-microscopySemin Arthritis Rheum201545221421926094164
  • Garcia-MartinEGarcia-CampayoJPuebla-GuedeaMFibromyalgia is correlated with retinal nerve fiber layer thinningPloS One2016119e016157427584145
  • de TommasoMNolanoMIannoneFUpdate on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy featuresJ Neurol2014261346147224366650
  • KernUSchneiderSBialasPTopisches Ambroxol zur Therapie des CRPS: Eine neue Option?Schmerz201630Suppl 2S59
  • KinlochRACoxPJNew targets for neuropathic pain therapeuticsExpert Opin Ther Targets20059468569816083337
  • CoggeshallRETateSCarltonSMDifferential expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 in normal and inflamed ratsNeurosci Lett20043551–2454814729231
  • StricklandITMartindaleJCWoodhamsPLReeveAJChessellIPMcQueenDSChanges in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint painEur J Pain200812556457217950013
  • FaberCGLauriaGMerkiesISGain-of-function Nav1.8 mutations in painful neuropathyProc Natl Acad Sci U S A201210947194441944923115331
  • HanCVasylyevDMacalaLJThe G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitabilityJ Neurol Neurosurg Psychiatry201485549950524006052
  • HuangJYangYZhaoPSmall-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neuronsJ Neurosci20133335140871409723986244
  • HuangJHanCEstacionMGain-of-function mutations in sodium channel Nav1.9 in painful neuropathyBrain2014137Pt 61627164224776970
  • BrusselmansGNogueiraHDe SchamphelaereEDevulderJCrombezGSkin temperature during cold pressor test in fibromyalgia: an evaluation of the autonomic nervous system?Acta Anaesthesiol Belg2015661192726103738
  • AbrahamsenBZhaoJAsanteCOThe cell and molecular basis of mechanical, cold, and inflammatory painScience2008321588970270518669863
  • NielsenLAHenrikssonKGPathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibitionBest Pract Res Clin Rheumatol200721346548017602994
  • DesmeulesJACedraschiCRapitiENeurophysiologic evidence for a central sensitization in patients with fibromyalgiaArthritis Rheum20034851420142912746916
  • VierckCJWongFKingCDMauderliAPSchmidtSRileyJL3rdCharacteristics of sensitization associated with chronic pain conditionsClin J Pain201430211912823629594
  • JarvisMFHonorePShiehCCA-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the ratProc Natl Acad Sci U S A2007104208520852517483457
  • VeneroniOMajRCalabresiMFaravelliLFarielloRGSalvatiPAnti-allodynic effect of NW-1029, a novel Na+ channel blocker, in experimental animal models of inflammatory and neuropathic painPain20031021–2172512620593
  • LittlejohnGNeuroinflammation in fibromyalgia and CRPS: top-down or bottom-up?Nat Rev Rheumatol2016124242
  • CassisiGSarzi-PuttiniPCasaleRPain in fibromyalgia and related conditionsReumatismo2014661728624938199
  • SumptonJEMoulinDEFibromyalgiaHandb Clin Neurol201411951352724365316
  • ChoyEHThe role of sleep in pain and fibromyalgiaNat Rev Rheumatol201511951352025907704
  • StaudRBrain imaging in fibromyalgia syndromeClin Exp Rheumatol2011296 Suppl 69S109S11722243558
  • GerhardtAEichWJankeSLeisnerSTreedeRDTesarzJChronic widespread back pain is distinct from chronic local back pain: evidence from quantitative sensory testing, pain drawings, and psychometricsClin J Pain201632756857926379077
  • BlumenstielKGerhardtARolkeRQuantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgiaClin J Pain201127868269021487289
  • WongFRodriguesASchmidtSVierckCJJrMauderliAPExtreme thermal sensitivity and pain-induced sensitization in a fibromyalgia patientPain Res Treat2010201091251322110917
  • NagakuraYTakahashiMNotoTDifferent pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury ratsBehav Brain Res2012226124224921945299
  • RenganathanMCumminsTRHormuzdiarWNWaxmanSGα-SNS produces the slow TTX-resistant sodium current in large cutaneous afferent DRG neuronsJ Neurophysiol200084271071810938298
  • LaiJGoldMSKimCSInhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8Pain2002951–214315211790477
  • ShieldsSDAhnHSYangYNav1.8 expression is not restricted to nociceptors in mouse peripheral nervous systemPain2012153102017203022703890
  • BhardwajHCArunachalamMKumarSLNavisSNeuroprotective and anti-nociceptive potential of ambroxol in oxaliplatin induced peripheral neuropathic pain in ratsBiol Med (Aligarh)2016821000268
  • OkifujiABradshawDHOlsonCEvaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functionsClin Rheumatol200928447547819172342
  • LermaCMartinezARuizNVargasAInfanteOMartinez-LavinMNocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severityArthritis Res Ther2011136R18522087605
  • Martinez-LavinMVidalMBarbosaREPinedaCCasanovaJMNavaANorepinephrine-evoked pain in fibromyalgia: randomized pilot studyBMC Musculoskelet Disord20023211860612
  • Martinez-LavinMSolanoCDorsal root ganglia, sodium channels, and fibromyalgia sympathetic painMed Hypotheses2009721646618845401
  • SchofieldGGPuhlHL3rdIkedaSRProperties of wild-type and fluorescent protein-tagged mouse tetrodotoxin-resistant sodium channel (NaV1.8) heterologously expressed in rat sympathetic neuronsJ Neurophysiol20089941917192718272876
  • FacerPPunjabiPPAbrariALocalisation of SCN10A gene product Nav1.8 and novel pain-related ion channels in human heartInt Heart J201152314615221646736
  • KosekEAltawilRKadetoffDEvidence of different mediators of central inflammation in dysfunctional and inflammatory pain: interleukin-8 in fibromyalgia and interleukin-1 β in rheumatoid arthritisJ Neuroimmunol2015280495525773155
  • KadetoffDLampaJWestmanMAnderssonMKosekEEvidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levelsJ Neuroimmunol20122421–2333822126705
  • JohnMAuBTJosePJExpression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroidsAm J Respir Cell Mol Biol199818184909448049
  • BetzRGlukokortikosteroide und Ambroxol hemmen die Sekretion entzundungsfördernder Zytokine in tracheobronchialen Epithelzellen: Mögliche Rolle des Transkriptionsfaktors NF-kappa B. [Glucocorticosteroids and ambroxol inhibit secretion of inflammatory cytokines in tracheobronchial epithelial cells: possible role of the NF-κB transcription factor]Pneumologie1997515491492 German9265149
  • LiWMaoBWangGA study of the mechanism of qingre huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretionZhong Xi Yi Jie He Xue Bao200868799805 Chinese18664347
  • LiWMaoBWangGEffect of tanreqing injection on treatment of acute exacerbation of chronic obstructive pulmonary disease with Chinese medicine syndrome of retention of phlegm and heat in feiChin J Integr Med201016213113720473738
  • YamayaMNishimuraHNadineLKOtaCKuboHNagatomiRAmbroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cellsArch Pharm Res201437452052923856970
  • WatkinsLRMaierSFImmune regulation of central nervous system functions: from sickness responses to pathological painJ Intern Med2005257213915515656873
  • MilliganEDWatkinsLRPathological and protective roles of glia in chronic painNat Rev Neurosci2009101233619096368
  • WallaceDJLinker-IsraeliMHalleguaDSilvermanSSilverDWeismanMHCytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot studyRheumatology (Oxford)200140774374911477278
  • PinteauxEParkerLCRothwellNJLuheshiGNExpression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cellsJ Neurochem200283475476312421347
  • GuoWWangHWatanabeMGlial-cytokine-neuronal interactions underlying the mechanisms of persistent painJ Neurosci200727226006601817537972
  • McEwenBSKaliaMThe role of corticosteroids and stress in chronic pain conditionsMetabolism201059Suppl 1S9S1520837196
  • StaudRFibromyalgia pain: do we know the source?Curr Opin Rheumatol200416215716314770104
  • AlbrechtDProtsenkoEMawlaIDoes brain glial activation have a role in fibromyalgia? A PBR28 PET studyPoster presented at: 16th World Congress on PainSeptember 26–30, 2016Yokohama, Japan
  • KosekEMartinsenSGerdleBThe translocator protein gene is associated with symptom severity and cerebral pain processing in fibromyalgiaBrain Behav Immun20165821822727448744
  • YoungerJMackeySFibromyalgia symptoms are reduced by low-dose naltrexone: a pilot studyPain Med200910466367219453963
  • BarkholtPSanchez-GuajardoVKirikDRomero-RamosMLong-term polarization of microglia upon α-synuclein overexpression in nonhuman primatesNeuroscience2012208859622342967
  • SuXMaguire-ZeissKAGiulianoRPriftiLVenkateshKFederoffHJSynuclein activates microglia in a model of Parkinson’s diseaseNeurobiol Aging200829111690170117537546
  • HoffmannAEttleBBrunoAAlpha-synuclein activates BV2 microglia dependent on its aggregation stateBiochem Biophys Res Commun2016479488188627666480
  • QiaoHZhangQYuanHElevated neuronal α-synuclein promotes microglia activation after spinal cord ischemic/reperfused injuryNeuroreport2015261165666126103121
  • ZhangWWangTPeiZAggregated α-synuclein activates microglia: a process leading to disease progression in Parkinson’s diseaseFASEB J200519653354215791003
  • KleinCPSperottoNDMacielISLeiteCESouzaAHCamposMMEffects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in miceNeuropharmacology201486576624929111
  • AlbrechtDSMacKiePJKarekenDADifferential dopamine function in fibromyalgiaBrain Imaging Behav201610382983926497890
  • LedermannKJeneweinJSprottHRelation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression: a [11C] raclopride PET-studyEur Neuropsychopharmacol201626232033026708319
  • Migdalska-RichardsADalyLBezardESchapiraAHAmbroxol effects in glucocerebrosidase and α-synuclein transgenic miceAnn Neurol201680576677527859541
  • ChandranVCoppolaGNawabiHA systems-level analysis of the peripheral nerve intrinsic axonal growth programNeuron201689595697026898779
  • Migdalska-RichardsAKoWKLiQBezardESchapiraAHOral ambroxol increases brain glucocerebrosidase activity in a nonhuman primateSynapse201771721967
  • WeiserTAmbroxol: a CNS drug?CNS Neurosci Ther2008141172418482096
  • Bromhexine [package insert]Ingelheim am Rhein, GermanyBoehringer Ingelheim2012
  • RöhnertPSchröderUHZiabrevaITagerMReymannKGStriggowFInsufficient endogenous redox buffer capacity may underlie neuronal vulnerability to cerebral ischemia and reperfusionJ Neurosci Res201290119320221971686
  • BagalSKChapmanMLMarronBEPrimeRStorerRISwainNARecent progress in sodium channel modulators for painBioorg Med Chem Lett201424163690369925060923
  • HanCHoeijmakersJGAhnHSNav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitabilityNeurology201278211635164322539570
  • HoeijmakersJGMerkiesISGerritsMMWaxmanSGFaberCGGenetic aspects of sodium channelopathy in small fiber neuropathyClin Genet201282435135822803682
  • FaberCGHoeijmakersJGAhnHSGain of function Nav1.7 mutations in idiopathic small fiber neuropathyAnn Neurol2012711263921698661
  • DabbyRSadehMBroitmanYYosovichKDickmanRLeshinsky-SilverEPainful small fiber neuropathy with gastroparesis: a new phenotype with a novel mutation in the SCN10A geneJ Clin Neurosci201626848826711856
  • BlackJAHoeijmakersJGFaberCGMerkiesISWaxmanSGNaV1.7: stress-induced changes in immunoreactivity within magno-cellular neurosecretory neurons of the supraoptic nucleusMol Pain201393923924059
  • BrouwerBAMerkiesISGerritsMMWaxmanSGHoeijmakersJGFaberCGPainful neuropathies: the emerging role of sodium channelopathiesJ Peripher Nerv Syst2014192536525250524
  • EberhardtMJLefflerASchmerz und Schmerzlosigkeit : Mutationen spannungsabhängiger Natriumkanäle. [Pain and analgesia: mutations of voltage-gated sodium channels]Schmerz20173111422 German27402262
  • UçeylerNHäuserWSommerCA systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndromeArthritis Rheum20085991279129818759260
  • DickIEBrochuRMPurohitYKaczorowskiGJMartinWJPriestBTSodium channel blockade may contribute to the analgesic efficacy of antidepressantsJ Pain20078431532417175203
  • WangSYCalderonJWangGKBlock of neuronal Na+ channels by antidepressant duloxetine in a state-dependent mannerAnesthesiology2010113365566520693878
  • StoetzerCPapenbergBDollTDifferential inhibition of cardiac and neuronal Na+ channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxineEur J Pharmacol201678311027130441
  • VanderWeideLASmithSMTrinkleyKEA systematic review of the efficacy of venlafaxine for the treatment of fibromyalgiaJ Clin Pharm Ther20154011625294655
  • SuterMRKirschmannGLaedermannCJAbrielHDecosterdIRufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated stateAnesthesiology2013118116017223221868
  • ChengKIWangHCChangLLPretreatment with intrathecal amitriptyline potentiates anti-hyperalgesic effects of post-injury intra-peritoneal amitriptyline following spinal nerve ligationBMC Neurol2012124422720761
  • SongJHHamSSShinYKLeeCSAmitriptyline modulation of Na+ channels in rat dorsal root ganglion neuronsEur J Pharmacol2000401329730510936487
  • BielefeldtKOzakiNWhiteisCGebhartGFAmitriptyline inhibits voltage-sensitive sodium currents in rat gastric sensory neuronsDig Dis Sci200247595996612018921
  • HurYKChoiISChoJHEffects of carbamazepine and amitriptyline on tetrodotoxin-resistant Na+ channels in immature rat trigeminal ganglion neuronsArch Pharm Res200831217818218365687
  • PatkarAAMasandPSKrulewiczSA randomized, controlled, trial of controlled release paroxetine in fibromyalgiaAm J Med2007120544845417466657
  • WiffenPJDerrySMooreRAAntiepileptic drugs for neuropathic pain and fibromyalgia: an overview of Cochrane reviewsCochrane Database Syst Rev201311CD01056724217986
  • ZhangJLYangJPZhangJRGabapentin reduces allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing expression level of Nav1.7 and p-ERK1/2 in DRG neuronsBrain Res20131493131823183040
  • NatkunarajahJAthertonDElmslieFMansourSMortimerPTreatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channelClin Exp Dermatol2009348e640e64219549232
  • DevigiliGEleopraRPierroTParoxysmal itch caused by gain-of-function Nav1.7 mutationPain201415591702170724820863
  • BiRYDingYGanYHNon-steroidal anti-inflammatory drugs attenuate hyperalgesia and block upregulation of trigeminal ganglionic sodium channel 1.7 after induction of temporomandibular joint inflammation in ratsChin J Dent Res2016191354226981605
  • HuangZJHsuELiHCRosnerALRupertRLSongXJTopical application of compound Ibuprofen suppresses pain by inhibiting sensory neuron hyperexcitability and neuroinflammation in a rat model of intervertebral foramen inflammationJ Pain201112114115220797917
  • GouldHJ3rdEnglandJDSoignierRDIbuprofen blocks changes in Nav1.7 and 1.8 sodium channels associated with complete Freund’s adjuvant-induced inflammation in ratJ Pain20045527028015219259
  • LefflerAFrankGKistnerKLocal anesthetic-like inhibition of voltage-gated Na+ channels by the partial µ-opioid receptor agonist buprenorphineAnesthesiology201211661335134622504149
  • HaeselerGFoadiNAhrensJDenglerRHeckerHLeuwerMTramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channelsPain20061261–323424416949748
  • WeibelRReissDKarchewskiLMu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout micePloS One201389e7470624069332
  • ReckzehJDie Wirkung des Sekretolytikums Ambroxol an neuronalen Natriumkanälen durch die Interaktion mit der Lokalanästhetikumbindungsstelle [PhD thesis]ErlangenFriedrich-Alexander-Universität Erlangen-Nürnberg2010
  • de MeyCKoelschSRichterEPohlmannTSousaREfficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat: a pooled analysisDrug Res (Stuttg)201666738439227281448
  • ChenotJFWeberPFriedeTEfficacy of ambroxol lozenges for pharyngitis: a meta-analysisBMC Fam Pract2014154524621446
  • WeiserTKinderKArndtKGaidaWAmbroxol unterdrückt hocheffektiv Symptome des chronischen, neuropathischen und inflammatorischen SchmerzesSchmerz200721Suppl 197
  • UçeylerNSommerCCytokine regulation in animal models of neuropathic pain and in human diseasesNeurosci Lett2008437319419818403115
  • StaudRCytokine and immune system abnormalities in fibromyalgia and other central sensitivity syndromesCurr Rheumatol Rev201511210911526088214
  • BoettgerMKWeberKGrossmannDSpinal tumor necrosis factor α neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor α during induction and maintenance of peripheral inflammationArthritis Rheum20106251308131820213802
  • DeLeoJAColburnRWNicholsMMalhotraAInterleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy modelJ Interferon Cytokine Res19961696957008887053
  • XuXJHaoJXAndell-JonssonSPoliVBartfaiTWiesenfeld-HallinZNociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve sectionCytokine1997912102810339417815
  • SommerCSchmidtCGeorgeAHyperalgesia in experimental neuropathy is dependent on the TNF receptor 1Exp Neurol199815111381429582261
  • SavinoWMendes-da-CruzDALepletierADardenneMHormonal control of T-cell development in health and diseaseNat Rev Endocrinol2016122778926437623
  • MalekHEbadzadehMMSafabakhshRRazaviAZaringhalamJDynamics of the HPA axis and inflammatory cytokines: insights from mathematical modelingComput Biol Med20156711226476562
  • GuptaDMorleyJEHypothalamic-pituitary-adrenal (HPA) axis and agingCompr Physiol2014441495151025428852
  • OrtegaEBoteMEGiraldoEGarciaJJAquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patientsScand J Med Sci Sports201222110411220536907
  • BoteMEGarciaJJHinchadoMDOrtegaEFibromyalgia: anti-inflammatory and stress responses after acute moderate exercisePloS One201389e7452424023948
  • BoteMEGarciaJJHinchadoMDOrtegaEInflammatory/stress feedback dysregulation in women with fibromyalgiaNeuroimmunomodulation201219634335122986514
  • WangHBuchnerMMoserMTDanielVSchiltenwolfMThe role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6 monthsClin J Pain20092511419158539
  • MendietaDde la Cruz-AguileraDLBarrera-VillalpandoMIIL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patientsJ Neuroimmunol2016290222526711564
  • XiaoYHaynesWLMichalekJERussellIJElevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rateRheumatol Int20133351259126423124693
  • RanzolinADuarteALBredemeierMEvaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia: a controlled cross-sectional studyCytokine201684252827209553
  • WatkinsLRWiertelakEPGoehlerLESmithKPMartinDMaierSFCharacterization of cytokine-induced hyperalgesiaBrain Res1994654115267982088
  • SchaibleHGNociceptive neurons detect cytokines in arthritisArthritis Res Ther201416547025606597
  • ImamuraMTarginoRAHsingWTConcentration of cytokines in patients with osteoarthritis of the knee and fibromyalgiaClin Interv Aging2014993994424959074
  • NakamuraTSchwanderSKDonnellyRCytokines across the night in chronic fatigue syndrome with and without fibromyalgiaClin Vaccine Immunol201017458258720181767
  • IannuccelliCDi FrancoMAlessandriCPathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndromeAnn N Y Acad Sci20101193788320398011
  • LiFWangWHuLLiLYuJEffect of ambroxol on pneumonia caused by Pseudomonas aeruginosa with biofilm formation in an endotracheal intubation rat modelChemotherapy201157217318021454975
  • TakedaKMiyaharaNMatsubaraSImmunomodulatory effects of ambroxol on airway hyperresponsiveness and inflammationImmune Netw201616316517527340385
  • YigitSInanirATekcanAInanirSTuralSAtesOAssociation between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish populationGene20135271626423644020
  • SturgillJMcGeeEMenziesVUnique cytokine signature in the plasma of patients with fibromyalgiaJ Immunol Res2014201493857624741634
  • WangHMoserMSchiltenwolfMBuchnerMCirculating cytokine levels compared to pain in patients with fibromyalgia: a prospective longitudinal study over 6 monthsJ Rheumatol20083571366137018528959
  • FengJZhangZWuXDiscovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencingPloS One201386e6503323762283
  • ChenYWangLPitzerALLiXLiPLZhangYContribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunctionJ Mol Med (Berl)201694121335134727783111
  • CorderoMDAlcocer-GomezECulicONLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10Antioxid Redox Signal20142081169118023886272
  • CorderoMDAlcocer-GomezEMarin-AguilarFMutation in cytochrome B gene of mitochondrial DNA in a family with fibromyalgia is associated with NLRP3-inflammasome activationJ Med Genet201653211312226566881
  • ZhangHLiFLiWWThe inflammasome as a target for pain therapyBr J Anaesth2016117669370727956668
  • GibbsBFDifferential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analoguesInt J Immunopathol Pharmacol200922491992720074455
  • KehSMFacerPSimpsonKDSandhuGSalehHAAnandPIncreased nerve fiber expression of sensory sodium channels Nav1.7, Nav1.8, and Nav1.9 in rhinitisLaryngoscope2008118457357918197135
  • ChungJHKimSAChoiBYThe association between overactive bladder and fibromyalgia syndrome: a community surveyNeurourol Urodyn2013321666922674758
  • BrandKLittlejohnGKristjansonLWisniewskiSHassardTThe fibromyalgia bladder indexClin Rheumatol200726122097210317476564
  • NickelJCTrippDAPontariMInterstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndromeJ Urol201018441358136320719340
  • DrewaTMłodzik-DanielewiczNTyrakowskiTThe influence of ambroxol and capsaicin on the isolated rabbit bladder wallActa Pol Pharm200562539940316459489
  • YangTYChenCSLinCLLinWMKuoCNKaoCHRisk for irritable bowel syndrome in fibromyalgia patients: a national database studyMedicine (Baltimore)20159410e61625761187
  • FengBLaJHSchwartzESGebhartGFIrritable bowel syndrome – methods, mechanisms, and pathophysiology: neural and neuroimmune mechanisms of visceral hypersensitivity in irritable bowel syndromeAm J Physiol Gastrointest Liver Physiol201230210G1085G109822403791
  • OsteenJDHerzigVGilchristJSelective spider toxins reveal a role for the Nav1.1 channel in mechanical painNature2016534760849449927281198
  • VillarrealCFSachsDCunhaFQParadaCAFerreiraSHThe role of NaV1.8 sodium channel in the maintenance of chronic inflammatory hypernociceptionNeurosci Lett20053862727716043287
  • JoshiSKMikusaJPHernandezGInvolvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain statesPain20061231–2758216545521
  • EkbergJJayamanneAVaughanCWμO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficitsProc Natl Acad Sci U S A200610345170301703517077153
  • HillsleyKLinJHStaniszADissecting the role of sodium currents in visceral sensory neurons in a model of chronic hyperexcitability using Nav1.8 and Nav1.9 null miceJ Physiol2006576Pt 125726716857712
  • LairdJMSouslovaVWoodJNCerveroFDeficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null miceJ Neurosci200222198352835612351708
  • HuSXiaoYZhuLNeonatal maternal deprivation sensitizes voltage-gated sodium channel currents in colon-specific dorsal root ganglion neurons in ratsAm J Physiol Gastrointest Liver Physiol20133044G311G32123139220
  • LiuMWoodJNThe roles of sodium channels in nociception: implications for mechanisms of neuropathic painPain Med201112Suppl 3S93S9921752183
  • Martinez-MartinezLAMoraTVargasAFuentes-IniestraMMartinez-LavinMSympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studiesJ Clin Rheumatol201420314615024662556
  • ChoiBYOhHJLeeYJSongYWPrevalence and clinical impact of fibromyalgia in patients with primary Sjögren’s syndromeClin Exp Rheumatol2016342 Suppl 96S9S13
  • HalilogluSCarliogluAAkdenizDKaraaslanYKosarAFibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activityRheumatol Int20143491275128024589726
  • OstuniPBotsiosCSfrisoPFibromyalgia in Italian patients with primary Sjögren’s syndromeJoint Bone Spine2002691515711858357
  • KimDKimHJHyonJYWeeWRShinYJEffects of oral mucolytics on tear film and ocular surfaceCornea201332793393823538621
  • IchikawaYTokunagaMShimizuHMoriuchiJTakayaMArimoriSClinical trial of ambroxol (Mucosolvan) in Sjögren’s syndromeTokai J Exp Clin Med1988133165169
  • ZhangZQWuQQHuangXMLuHPrevention of respiratory distress syndrome in preterm infants by antenatal ambroxol: a meta-analysis of randomized controlled trialsAm J Perinatol201330752953623229957
  • ZwisslerBPharmakotherapie bei akutem LungenversagenJ Anaesth Intensivbehandl2002915967
  • LuertiMLazzarinACorbellaEZavattiniGAn alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasoneJ Perinat Med19871532272383323457
  • ChiaraOBPadalinoPGuadalupiPBigalettoINespoliAThe prevention of postoperative prevention ARDS: double-blind testing about the effects of ambroxol on pulmonary gas exchangeUrgent Chirurg Comment198361–216
  • SchillingsGJAmbroxol in the treatment of ARDS in polytraumatised patients: a reportKlinikarzt199221828
  • KimyaYKüçükkömürcüSOzanHUncuGAntenatal ambroxol usage in the prevention of infant respiratory distress syndrome: beneficial and adverse effectsClin Exp Obstet Gynecol19952232042117554258
  • BaranwalAKMurthyASSinghiSCHigh-dose oral ambroxol for early treatment of pulmonary acute respiratory distress syndrome: an exploratory, randomized, controlled pilot trialJ Trop Pediatr201561533935026130623
  • VerginHBishop-FreudlingGBMiczkaMNitscheVStrobelKMatzkiesFUntersuchungen zur Pharmakokinetik und Bioaquivalenz unterschiedlicher Darreichungsformen von Ambroxol. [The pharmacokinetics and bioequivalence of various dosage forms of ambroxol]Arzneimittelforschung1985351015911595 German4074420
  • ZimranAAltarescuGElsteinDPilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher diseaseBlood Cells Mol Dis201350213413723085429
  • MalerbaMPonticielloARadaeliABensiGGrassiVEffect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD: double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST trial)Pulm Pharmacol Ther2004171273414643168
  • DongCWangGLiBAnti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthmaRespir Physiol Neurobiol20121811212822226856
  • BazzichiLRossiAMassimettiGCytokine patterns in fibromyalgia and their correlation with clinical manifestationsClin Exp Rheumatol200725222523017543146
  • SuzukiMTeramotoSMatsuseTInhibitory effect of ambroxol on superoxide anion production and generation by murine lung alveolar macrophagesJ Asthma19983532672729661679
  • RamachandraRMcGrewSYBaxterJCKivericEElmslieKSTetrodotoxin-resistant voltage-dependent sodium channels in identified muscle afferent neuronsJ Neurophysiol201210882230224122855776
  • KernNUWeiserTTopisches Ambroxol zur Behandlung neuropathischer Schmerzen: Eine erste klinische Beobachtung. [Topical ambroxol for the treatment of neuropathic pain: a first clinical observation]Schmerz2015296632640 German26597641
  • TaiHWangZGongHAutophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescenceAutophagy20171319911327791464
  • OrtegaEGarciaJJBoteMEExercise in fibromyalgia and related inflammatory disorders: known effects and unknown chancesExerc Immunol Rev200915426519957871
  • Martinez-LavinMSmall fibre neuropathy, fibromyalgia and dorsal root ganglia sodium channelsBrain2013136Pt 9e24623729476
  • AkopianANSouslovaVEnglandSThe tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathwaysNat Neurosci19992654154810448219
  • RozaCLairdJMSouslovaVWoodJNCerveroFThe tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of miceJ Physiol2003550Pt 392192612824446
  • StaudRIs it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal painCurr Rheumatol Rep201012644845420882373
  • GiraldesALSalomaoRLealPDBrunialtiMKSakataRKEffect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: a randomized double-blind studyInt J Rheum Dis2016191094695327309886
  • VlainichRIssyAMSakataRKEffect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgiaClin J Pain201127428528821178598